FULVICIN-U/F Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fulvicin-u/f, and what generic alternatives are available?
Fulvicin-u/f is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in FULVICIN-U/F is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
Summary for FULVICIN-U/F
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 4,630 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FULVICIN-U/F at DailyMed |
Pharmacology for FULVICIN-U/F
Drug Class | Tubulin Inhibiting Agent |
Physiological Effect | Decreased Mitosis Microtubule Inhibition |
Anatomical Therapeutic Chemical (ATC) Classes for FULVICIN-U/F
US Patents and Regulatory Information for FULVICIN-U/F
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | FULVICIN-U/F | griseofulvin, microsize | TABLET;ORAL | 060569-002 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | FULVICIN-U/F | griseofulvin, microsize | TABLET;ORAL | 060569-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |